Prognostic and Predictive Value of Centrally Reviewed Ki-67 Labeling Index in Postmenopausal Women With Endocrine-Responsive Breast Cancer: Results From Breast International Group Trial 1-98 Comparing Adjuvant Tamoxifen With Letrozole

PURPOSE: To evaluate the prognostic and predictive value of Ki-67 labeling index (LI) in a trial comparing letrozole (Let) with tamoxifen (Tam) as adjuvant therapy in postmenopausal women with early breast cancer. PATIENTS AND METHODS: Breast International Group (BIG) trial 1-98 randomly assigned 8,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Viale, Giuseppe, Giobbie-Hurder, Anita, Regan, Meredith M., Coates, Alan S., Mastropasqua, Mauro G., Dell'Orto, Patrizia, Maiorano, Eugenio, MacGrogan, Gaëtan, Braye, Stephen G., Öhlschlegel, Christian, Neven, Patrick, Orosz, Zsolt, Olszewski, Wojciech P., Knox, Fiona, Thürlimann, Beat, Price, Karen N., Castiglione-Gertsch, Monica, Gelber, Richard D., Gusterson, Barry A., Goldhirsch, Aron
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2008
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2651094/
https://ncbi.nlm.nih.gov/pubmed/18981464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.17.0829
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados